AstraZeneca PLC
www.astrazeneca.com
Latest From AstraZeneca PLC
Keeping Track: A Fresh Wave Of Approvals
New Active Substance First Launches Rebound In 2017
2017 was the second-best year for new drug launches worldwide since the start of the millennium, new research by Informa Pharma Intelligence's Pharmaprojects has found.
Pipeline Watch: Phase III Updates For Eravacycline, Opdivo And Keytruda
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
AstraZeneca Bolstering India Play With $90m Investment Plan
AstraZeneca expects to invest $90m over five years to shore up its footprint in India – a market where the Anglo-Swedish major has introduced a string of new products but has also had a fair share of challenges.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Inflammation
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
AstraZeneca PLC
- Acerta Pharma BV
- Ardea Biosciences Inc.
- Arrow Therapeutics Ltd.
- Astra Arcus
- Astra Draco AB
- Astra GMBH
- Astra Hassle AB
- Astra Japan Ltd.
- AstraZeneca AB
- AstraZeneca KK
- AstraZeneca LP
- AstraZeneca Pharma India Ltd.
- AstraZeneca Pharmaceuticals LP
- AstraZeneca UK Ltd.
- Australian Monoclonal Antibody Development Pty Ltd
- Cambridge Research Biochemicals Inc.
- Cambridge Research Biochemicals Ltd.
- ICI Americas Inc.
- ICI Australia
- KuDOS Pharmaceuticals Ltd.
- Laboratorio Ifesa SA
- MedImmune Inc.
- MedImmune LLC
- Novexel SA
- Omthera Pharmaceuticals Inc.
- Pearl Therapeutics Inc.
- Salick Health Care Inc.
- Simes SRL
- Stuart Disease Management Services
- Stuart Pharmaceuticals Inc.
- Symbicom AB
- Zeneca Agrochemicals
- Zeneca Group PLC
- Zeneca Inc.
- Zeneca Pharma Inc.
- Zeneca Pharmaceuticals
- ZS Pharma Inc.
- Senior Management
-
Pascal Soriot, CEO
Marc Dunoyer, CFO
Sean Bohen, MD, PhD, EVP, Global Medicines Dev. & CMO - Contact Info
-
AstraZeneca PLC
Phone: (44) 20 7604 8000
2 Kingdom St.
London, W2 6BD
UK
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice